{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:04:44Z","timestamp":1767650684015,"version":"3.44.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.mayocp.2023.03.011","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T06:03:09Z","timestamp":1682920989000},"page":"647-649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reviewing the Evidence of the Association Between Baclofen and Encephalopathy"],"prefix":"10.1016","volume":"98","author":[{"given":"Flory T.","family":"Muanda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica M.","family":"Sontrop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit X.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.mayocp.2023.03.011_bib3","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.2019.17725","article-title":"Association of baclofen with encephalopathy in patients with chronic kidney disease","volume":"322","author":"Muanda","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mayocp.2023.03.011_bib4","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.kint.2020.04.047","article-title":"Baclofen has a risk of encephalopathy in older adults receiving dialysis","volume":"98","author":"Chauvin","year":"2020","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.mayocp.2023.03.011_bib5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.mayocp.2022.11.004","article-title":"Baclofen and the risk of encephalopathy: a real-world, active-comparator cohort study","volume":"98","author":"Hwang","year":"2023","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.mayocp.2023.03.011_bib6","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211022197","article-title":"Baclofen therapeutics, toxicity, and withdrawal: a narrative review","volume":"9","author":"Romito","year":"2021","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.mayocp.2023.03.011_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.pa.33.040193.000545","article-title":"GABAB receptor pharmacology","volume":"33","author":"Bowery","year":"1993","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"5","key":"10.1016\/j.mayocp.2023.03.011_bib8","first-page":"255","article-title":"The enigma of baclofen toxicity","volume":"25","author":"Molderings","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.mayocp.2023.03.011_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2296-13-91","article-title":"How to improve drug dosing for patients with renal impairment in primary care\u2014a cluster-randomized controlled trial","volume":"13","author":"Erler","year":"2012","journal-title":"BMC Fam Pract"},{"issue":"6","key":"10.1016\/j.mayocp.2023.03.011_bib10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.ajkd.2011.07.022","article-title":"Use of clinical decision support systems for kidney-related drug prescribing: a systematic review","volume":"58","author":"Tawadrous","year":"2011","journal-title":"Am J Kidney Dis"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619623001349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619623001349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:39:22Z","timestamp":1758418762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619623001349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0025619623001349"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2023.03.011","relation":{},"ISSN":["0025-6196"],"issn-type":[{"type":"print","value":"0025-6196"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reviewing the Evidence of the Association Between Baclofen and Encephalopathy","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2023.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.11.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}